XEN-D0501 Research: What the New Obesity Trial Tests
Evidence & Research Status Evidence LevelEarly Human Testing — No Results Published FDA StatusNot FDA-approved for human use Regulatory StatusResearch
Research Briefs
Summaries of current peer-reviewed research.
HRS-1596: What Novo Licensed From Hengrui
Evidence & Research Status Evidence LevelPreclinical / Early-Stage Research FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO)
K-554 Peptide: What Novo Acquired From Kallyope
Evidence & Research Status Evidence LevelPreclinical / Early-Stage Research FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO)
Overlapping Pathways in Circadian, Repair and Mitochondrial Biology
Published research increasingly treats sleep, tissue repair and cellular energy as one connected system rather than three separate problems. How the literature links them.
ASC36: What Ascletis’ Phase 1 Amylin Agonist Trial Is Testing
Update — October 26, 2026 On October 21, 2026, Ascletis reported preclinical pharmacokinetic data for its oral amylin-pathway program. In
GLP-1 Receptor Agonists: Mechanisms in the Literature
Evidence & Research Status Evidence LevelMixed — FDA-Approved to Preclinical (see table below) FDA StatusVaries by indication and by branded
CRB-913 Obesity Research: What CANYON-1 Is Actually Measuring
Evidence & Research Status Evidence LevelEarly-Stage Human Data (Phase 1) FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only
Petrelintide: What the Trial Data Shows
Evidence & Research Status Evidence LevelEarly-Stage Human Data (Phase 1b) FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only
NBIP-1968: Neurocrine’s Triple Agonist
Evidence & Research Status Evidence LevelEarly Human Testing — No Results Published FDA StatusNot FDA-approved for human use Regulatory StatusResearch
Real-World GLP-1 Outcomes vs Trial Results
Evidence & Research Status Evidence LevelExtensive Human Clinical Data FDA StatusNot FDA-approved for human use Regulatory StatusResearch Use Only (RUO)